VM

VALARIE MOLAISON

NEUROCRINE BIOSCIENCES, INC · San Diego, CA · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
4 agencies contacted
Activity
filings by quarter
Works on

Background

Career
San Diego, CA
2024 - present

Specific issues

Issues related to implementation of the Inflation Reduction Act, P.L. 117-169, including potential changes to the structure of and reimbursement for Medicare Part D. H.R. 5539 - Orphan Cures Act H.R. 7174 - Ensuring Pathways to Innovative Cures (EPIC) Act.
Medicare/Medicaid · 2024 Q3
Issues related to the Research and Development (R&D) tax credit including the Tax Relief for American Families and Workers Act of 2024, H.R. 7024.
Taxation/Internal Revenue Code · 2024 Q3
Regulatory and legislative healthcare issues related to pharmaceutical development, approval, reimbursement, and patient access. Issues related to the diagnosis and treatment of Tardive Dyskinesia. Issues related to telehealth including the Telemental Health Care Access Act of 2023, H.R. 3432, and the Telehealth Modernization Act of 2024, H.R. 7623. H.R. 7085 - BIOSECURE Act.
Health Issues · 2024 Q3
Support appropriations report language and funding to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Budget/Appropriations · 2024 Q3
Regulatory and legislative healthcare issues related to pharmaceutical development, approval, reimbursement, and patient access. Issues related to the diagnosis and treatment of Tardive Dyskinesia. Issues related to telehealth including the Telemental Health Care Access Act of 2023, H.R. 3432. H.R. 7085 - BIOSECURE Act.
Health Issues · 2024 Q2

Clients

$██,███ / qtrUnlock

Filing history

2024 Q3
NEUROCRINE BIOSCIENCES, INC
Q3lda.gov →
2024 Q2
NEUROCRINE BIOSCIENCES, INC
Q2lda.gov →
2024 Q1
NEUROCRINE BIOSCIENCES, INC
Q1lda.gov →
Showing recent filings · full history on lda.gov